We recently compiled a list of the 11 AI News You Should Not Miss. In this article, we are going to take a look at where ...
Analysts at Roth Capital issued their Q1 2026 EPS estimates for shares of Uranium Energy in a research report issued to clients and investors on Monday, December 9th. Roth Capital analyst J. Reagor ...
Roth MKM analyst Matt Koranda raised the firm’s price target on Byrna Technologies (BYRN) to $23 from $22 and keeps a Buy rating on the shares.
Roth MKM last night initiated coverage of Entrada Therapeutics (TRDA) with a Buy rating and $29 price target Entrada is an ...
Yext (NYSE:YEXT – Get Free Report)‘s stock had its “buy” rating reissued by equities research analysts at Roth Mkm in a report released on Tuesday,Benzinga reports. They presently have a $10.50 target ...
Roth MKM raised the firm’s price target on Kroger (KR) to $56 from $52 and keeps a Neutral rating on the shares after its Q3 results. With a comp store sales beat, Kroger returned to ...
Days after investment bank Roth MKM upgraded its rating on the Tesla Inc. TSLA stock from “neutral” to “buy,” other analysts have hiked price targets. What Happened: Bank of America ...
On Friday, Roth/MKM initiated coverage on shares of CervoMed (NASDAQ:CRVO), a pharmaceutical company, with a Buy rating and a 12-month price target of $45.00. The firm's positive outlook is based ...
Roth MKM analyst Boobalan Pachaiyappan last night initiated coverage of Gain Therapeutics (GANX) with a Buy rating and $7 price target The firm says GT-02287, a potential $4B drug that ...
Roth MKM analyst Philip Shen maintained a Buy rating on Sunnova Energy International (NOVA – Research Report) today and set a price target of ...